Related Experiment Video
Updated: Aug 17, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Voriconazole: review of a broad spectrum triazole antifungal agent
Grzegorz Kofla1, Markus Ruhnke
1Division of Oncology-Hematology, Department of Medicine 2, Humboldt University Berlin, Charité Campus Mitte, Berlin, Germany.
Abstract:
Voriconazole is a second-generation triazole antifungal agent, structurally derived from fluconazole with an extended spectrum of activity against a wide variety of yeasts and moulds. Developed for the treatment of life-threatening fungal infections, it appears to be an effective therapy option for invasive aspergillosis, fluconazole-resistant candidiasis and refractory or less-common invasive fungal infections. It is available for both oral and intravenous administration and is characterised by an acceptable safety and tolerability spectrum.
Related Concept Videos
Antifungal Agents
Antiprotozoal Agents
Candidiasis
Cryptococcal Meningitis
Antiviral Nucleoside Inhibitors
Anthelminthic Agents
